Bad news: The medicine that came to Kosovo from America turns out that it doesn't help against corruption, the study finds

The report published by the Journal of Zheijang University in China tested whether the coronary patients who took the drug rather than those who didn't take it, and found that there was no difference, writes Independent, translates Periscope.

This limited study did these tests only in 30 patients and goes against the study in France, which had been tested on 40 patients. In France the study found that the virus was removed from the patient when the drug was used in combination with antibiotics.

The study in France encouraged President Donald Trump to show the potential benefits of this drug. Last week, he called his combination a “game saver” even though the Drug and Food Administration warned it might not work and that it still had to be approved for Ovid-19.

Yet, this administration approved drug testing in New York to patients with a more serious condition to see if combining hydroxyclorokine with antibiotics would help.

These tests began Tuesday, and Governor Andrew Cuomo said he was <x0-optimistic” for results.

Nevada Governor Steve Sisolak banned the use of hydroxyclorokina to treat patients with coronarys after counterproliferation reports on whether this drug would function against the virus.

Mr. Sisolak said there was no consensus among Nevada experts or doctors that the medicine could work on patients.

This drug has recently come to Kosovo, and it has also been treated by coronary patients in Kosovo. Part of these drugs have been purchased, while part has been donated as a donation, but the Health Ministry has not shown the donor's name. /Periscope